BofA raised the firm’s price target on Tempus AI (TEM) to $70 from $68 and keeps a Neutral rating on the shares. The firm, which reiterates a Neutral rating on AI-enabled precision medicine company given what it calls “an already premium valuation,” remains constructive on the business and key markets and cites peer group expansion for its increased price target
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade TEMPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Mixed options sentiment in tempus AI Inc Class A with shares down 2.58%
- Bullish flow in tempus AI Inc Class A with shares up 1.33%
- Tempus AI enters AI collaboration with The Abrams Research Center
- Mixed options sentiment in tempus AI Inc Class A with shares up 2.05%
- Moderately bullish activity in tempus AI Inc Class A with shares up 1.99%